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Infection by the human immunodeficiency virus (HIV) is a worldwide public health 
concern. In the Southern African region, the HIV and AIDS pandemic has grown faster than 
in any other parts of the world, from infection rate, in pregnant women, of 0.8% in 1990 to 
30.2% in 2005 in South Africa and 29.4% in 2009 (DOH, 2000; DOH, 2006; DOH 2010). Due to 
its destructive effect on the immune system, HIV infection further exposes the individual to 
multiple opportunistic infections. From the beginning of the HIV pandemics in the 1980s, 
gastrointestinal diseases have been demonstrated to be a major problem in patients with 
HIV and AIDS, and diarrhea is reported in up to 60% of patients with AIDS in developed 
countries and up to 90% in developing countries (Siddiqui et al., 2007; Silva et al., 2010). 
Recent studies by Bradshaw et al., (2005) have indicated that HIV/AIDS is the leading cause 
of premature mortality for all provinces in South Africa and mortality due to pre-
transitional causes, such as diarrhea, is more pronounced in the poorer and more rural 
provinces. In Limpopo Province as well as other poorer provinces in South Africa, diarrheal 
diseases are the first cause of mortality after HIV/AIDS (Bradshaw et al., 2005). However, 
data on specific etiologies is sparse (Obi and Bessong, 2002) and such information will be 
crucial in the specific management of HIV and AIDS.  
Although diarrheagenic organisms have been studied in different parts of the African 
continent, most research activities targeted specific organisms and their role in the 
production of diarrhea with little consideration to the presence of other organisms, their role 
in the production of inflammation which might be a considerable part of the pathogenesis of 
the organisms (Nel et al., 2010). Elsewhere, the combination of environmental factors, new 
ways of living and structural changes in the genetic material of most microorganisms have 
led to the appearance of emerging and re-emerging diseases (Lashley, 2006). Combined to 
the increasing recognition of a widening array of enteric pathogens associated with illnesses 
of the gastrointestinal tract, these factors highlight the growing need for the understanding 
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of the epidemiology and transmission of the different organisms involved in infectious 
diarrhea in specific settings, using the more specific and sensitive molecular tools, for a 
better management of these diseases and the improvement of the quality of life of the 
concerned populations. 
Gastrointestinal infections are major causes of morbidity and mortality throughout the 
world and particularly in developing countries where mortality rates due to infectious 
diarrhea could be as high as 56% (WHO, 2004). Children and young adults are the most 
affected, particularly in regions with limited resources and where hygienic measures are not 
strictly followed (Guerrant et al., 2005; Opintan et al., 2010). In Africa, diarrhea has been 
estimated to be responsible for 25 to 75% of all childhood illnesses (Kirkwood, 1991), and 
episodes of diarrhea lead to about 14% of outpatient visits, 16% of hospital admissions, and 
account for an average of 35 days of illness per year in children less than five years old 
(Greenwood et al., 1987).  Causes of diarrhea in endemic areas include a wide variety of 
bacteria, viruses and parasites. Intestinal parasites are associated with serious clinical 
disease and mortality, and are known to cause malnutrition, growth, learning and physical 
development impairment in children. It is thus necessary to have a fairly accurate picture of 
the situation in order to target intervention strategies in affected areas.  
It has been suggested that intestinal parasites occur at unacceptably high levels throughout 
South Africa. However, accurate prevalence data for the whole country are not currently 
available. With the exception of mapping being undertaken in KwaZulu-Natal, the medical 
geography of intestinal parasitic infections is stale, very fragmented and almost useless for 
planning, implementing and monitoring effective interventions (Fincham et al., 1997). In 
Cape Town, surveys at primary schools in urban and rural communities have revealed soil 
transmitted helminthiasis prevalence range between 7% and 83% (Kirkwood, 1991).  
However, there is scanty information, if any, on the prevalence of intestinal parasitic 
infections in the Limpopo Province.  
Bacterial organisms such as Campylobacter spp, Salmonella spp, Shigella spp and different 
groups of enteropathogenic E. coli are well known as causes of gastrointestinal diseases all 
over the world. These organisms have been demonstrated in water and stools from the 
Vhembe district (Obi et al., 2004; Larsen et al., 2011). Infections by most of these organisms 
can be asymptomatic, or can be treated with rehydration solutions particularly in case of 
viruses and some bacteria. The use of antibiotics might shorten the duration of diarrhea and 
limit the shedding of the organisms which otherwise might continue to pollute the 
environment and pose further risk of infections. Antibiotics such as erythromycin and 
gentamicin have been proven to be effective in some communities. However, antibiotic 
resistance is an overgrowing problem and there is a need to monitor the susceptibility of 
common bacterial isolates to drugs used in the community in order to provide guidelines for 
the empirical treatment of bacterial infections.  
Diarrhea is a common final expression of infection with a myriad of pathogens. Appropriate 
management requires knowledge of the setting in which the patient became ill, the 
underlying disease state, presence and extent of dehydration and other clinical symptoms, 
travel history, known outbreaks, and pathogenic mechanism (invasive or toxigenic) and the 
physical findings and laboratory results at the time the patient presented with the condition 
(de Truchis and de Truchis, 2007; Beatty, 2010). Optimal evaluation and treatment of each of 
these infections (as well as of cases caused by noninfectious organisms) can limit the 
duration of illness, the morbidity rate, the cost of work-up, and the spread of secondary 
infection (Goodman and Segreti, 1999). Although the differential diagnosis of infectious 
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diarrhea is broad, the clinical history can help guide the clinician toward the appropriate 
evaluation for each patient. For those patients with diarrhea of 2-3 days' duration, work-up 
is rarely necessary unless fever, bloody diarrhea, or severe abdominal pain is present. A 
detailed history of recent travel (within 6 months), recent antibiotic use (within 6-8 weeks), 
and contact with individuals who are ill and specific dietary ingestions during foodborne 
outbreaks can suggest an infectious etiology (DuPont, 1997). Infection with HIV is also a 
common cause of diarrhea. Therefore, medical history should include looking for risk 
factors for HIV and other comorbid illness that may result in immunosuppression (eg, 
diabetes, liver disease, organ transplantation) (Quinn et al., 1983). 
Clinical signs of dehydration, including dry mucous membranes, low urine output, or 
tachycardia, suggest severe infection. Other symptoms of severe infection include fever, 
severe abdominal pain, distension of the abdomen, and decreased bowel sounds. Although 
these findings are less helpful in determining the etiology of the diarrhea, they are helpful in 
deciding if the patient requires any immediate treatment or hospitalization.  
Most cases of acute infectious diarrhea do not need medical evaluation or intervention 
because they will resolve spontaneously and rapidly (Herickstad et al., 2002). However, if 
patients have any of the following clinical signs or presentations, they should undergo 
medical evaluation: (1) dehydration secondary to profuse watery diarrhea or inability to 
tolerate oral fluids; (2) fever (temperature >= 38.5 °C or 101.3 °F); (3) stools containing blood 
and mucus; (4) passage of 6 or more stools in a 24-hour period or duration of illness 48 
hours or longer; (5) diarrhea with severe abdominal pain in patients 50 years of age or older; 
or (6) diarrhea in individuals 70 years of age or older or in those with known 
immunosuppression (eg, AIDS, transplant patients, patients who have recently received 
chemotherapy) (Guerrant et al., 2001). 
The distinction between inflammatory and non-inflammatory diarrhea has long been useful 
in the diagnosis of diarrhea and in the creation of treatment algorithms for managing 
diarrhea (Guerrant et al., 2001; Thielman and Guerrant, 2004). The highly inflammatory 
diarrheas (or overt dysenteries) are caused by cultivable and potentially treatable pathogens, 
such as Shigella species, Campylobacter jejuni,  E. histolytica, C. difficile and more recently 
Enteroaggregative E. coli and sometimes, Salmonella species (Huang et al., 2003; Jiang et al., 
2010; Hou et al., 2010). The currently available tests, microscopy for fecal leukocytes and an 
immunoassay for fecal lactoferrin (a simpler, quicker and more sensitive marker for the 
presence of fecal leukocytes), provide supporting evidence of inflammatory diarrhea and 
may be useful when such clinical features are equivocal (Victora et al., 2000; Mercado et al, 
2011). Recent studies have indicated that infections with Cryptosporidium parvum or Giardia 
species may result in mild intestinal inflammation that leads to detectable levels of fecal 
lactoferrin (Alcantara et al., 2003). In equivocal cases, the negative predictive value of fecal 
lactoferrin testing may help to determine the need for routine bacteriologic culture for 
organisms such as Campylobacter spp, Salmonella spp, and Shigella spp (Thielman and 
Guerrant, 2004). 
Stool cultures are considered to be the gold standard for the diagnosis of bacterial causes of 
gastroenteritis. However, their clinical use is limited to organisms that are routinely 
cultured (Choi et al., 1996). The choice of the organisms to be cultured for depends on 
epidemiological data available for the region as well as outbreak and travel history. For 
example, most laboratories only attempt to culture for Salmonella spp, Shigella spp, and 
Campylobacter spp. Culture has also been used for diagnosis purposes in cases of Entamoeba 
histolytica suspicion. However this method is cumbersome and lack both sensitivity and 
www.intechopen.com
 
Microbes, Viruses and Parasites in AIDS Process 
 
146 
specificity for the detection and identification of E. histolytica (Abd-Alla et al., 1998). 
Considerable savings may be achieved if cultures for bacterial enteric pathogens are 
restricted to samples from patients hospitalized for ≤ 3 days (Valenstein et al., 1996). 
Common organisms that can cause diarrhea, such as enteroinvasive E. coli and 
enterotoxigenic E. coli are not routinely looked for since these organisms can only be 
identified by molecular methods which are mostly restricted to research laboratories or few 
laboratories in developed countries. Unusual organisms such as Yersinia species and Vibrio 
species, which may be important in certain locations, are not routinely tested for.  
Microscopy is the traditional method commonly used in developing countries for the 
detection of ova and trophozoites of parasites and some times can be helpful in the detection 
of bacterial organisms such as Campylobacter spp. In developed countries such as the USA, 
stool examination for ova and parasites is generally performed particularly if a patient is 
potentially immunosuppressed or returning from a developing country. However, in Africa 
microscopy is the mostly used method for diagnosis of parasitic infections and can be used 
in direct stools examination, or after staining by different methods such as the simplified 
Ritchie technique and Ziehl Neelsen modified coloration (Kassi et al., 2004). The method 
used also depends on the suspected microorganism. In some cases such as in 
cryptosporidiosis where shedding of oocysts can be intermittent, up to 3 stool specimens 
may be needed for diagnosis (Goodgame et al., 1993; Chappell et al., 1996). By use of a 
modified acid-fast stain (Kinyoun), oocysts appear as red spheres of 4 - 6µm in diameter; no 
other organisms should be easily confused with Cryptosporidium species on the basis of size 
and appearance. Unfortunately, acid-fast staining is relatively insensitive, requiring 10,000 
oocysts/g of watery stool and 500,000 oocysts/g of formed stool to make the diagnosis. 
Microscopy remains the best available test for acid-fast Cyclospora cayetanensis infections.  
Traditionally, infections by Giardia as well as other organisms such as E. histolytica, 
Dientamoeba fragilis, Balantidium coli and other helminthes have been diagnosed by means of 
ova and parasite examination of fecal or small bowel specimens (including small bowel 
specimens obtained using the "string" test) (Stark et al., 2006; Kurniawanet al., 2009). The 
physical characteristics of the cysts or ova may prove helpful in the differentiation of the 
organisms involved. For example, Giardia cysts are ovoid or ellipsoid and measure 11 15 μm 
in diameter while trophozoites are approximately the same size, with 2 anteriorly placed 
nuclei and 8 flagella best visualized by staining with trichrome or with the iron hematoxylin 
method (Shetty et al., 1988; El-Naggar et al., 2006). Although microscopy might be useful in a 
rural setting, its use is limited by its insensitivity and lack of specificity which might lead to 
over diagnosis of some infections such as those of E. histolytica (Kebede et al., 2003; Nesbitt et 
al., 2004). More sensitive methods have thus been introduced which are easier and have 
higher sensitivities and specificities.    
The development of molecular methods has tremendously improved the detection and 
identification of infecting agents. A variety of PCRs have been described for the detection of 
different bacteria such as Shigella, Salmonella, Campylobacter spp, diarrheagenic E. coli, 
Aeromonas spp and Plesiomonas spp as well as parasitic organisms such as Cryptosporidium, E. 
histolytica, Micrsoporidia, Cyclospora, Isospora and Giardia species (Marshall et al., 1999; 
Sturbaum et al., 2001, Larsen et al., 2011) . The sensitivity of detection by PCR is greater than 
that by microscopy, making it of great use for detection of low numbers of parasites in stool 
samples (Bialek et al., 2002). PCR for the detection of Cryptosporidium species, for example, 
has a sensitivity of 93% and a specificity of 95%, compared with 67% and 99%, respectively, 
for the Direct immunofluorescence assay (DFA) assay and 68% and 58%, respectively, for 
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Enzyme Immuno Assay (EIA) (Bushen et al., 2004; Kar et al., 2011). In addition to 
identifying protozoa, the use of real-time PCR restriction fragment length polymorphism 
(RFLP) analysis can detect as few as 5 Cryptosporidium oocysts and can differentiate between 
5 genotypes and, more recently, subtypes (Limor et al., 2002). PCR-RFLP analysis is more 
sensitive, as it may detect 50 500 oocysts/mL of liquid stool or <1 pg of DNA and <10 
oocysts from environmental samples (Sturbaum et al., 2001). Detection of diarrheagenic E. 
coli such as EAEC has required a specific test for one of the characteristic virulence traits of 
this group of organisms. Because an entire cassette of potential virulence traits is regulated 
by the transcriptional activator AggR, some have proposed that genetic probes for this trait 
may be the single best test for EAEC at the present time, and such genetic probes have been 
incorporated into a multiplex PCR test (Cerna et al., 2003). With the introduction of easier, 
more-sensitive methods that reduce labor, time, and reagent costs, the possibility of 
combining assays for the detection of different targets into one assay has become a 
possibility. A multiplex real-time PCR and an oligonucleotide microarray may be new 
methods for the detection of Campylobacter spp, Salmonella spp, Shigella spp, E. histolytica, 
Giardia lamblia, and C. parvum, with excellent, perhaps unprecedented, sensitivity and 
specificity in either fecal or water samples (Wang et al., 2004; Verweij et al., 2004). Work on 
these and potential new methods to detect fecal contamination in water may help to identify 
and ameliorate inadequate sanitation and contaminated water that perpetuates the 
devastating illness burdens associated with enteric infections around the world (Dillingham 
and Guerrant, 2004).  
The causes of infectious diarrhea include a wide array of viruses, bacteria, and parasites, 
many of which have been recognized only in the last decade or two (Steiner et al., 2006). The 
occurrence of the different pathogens depends on region. While enterotoxigenic Escherichia 
coli and rotaviruses predominate in developing areas, Norwalk-like viruses, Campylobacter 
jejuni, and cytotoxigenic Clostridium difficile are seen with increasing frequency in developed 
areas; and Shigella, Salmonella, Cryptosporidium species, and Giardia lamblia are found 
throughout the world (Taylor, 1993). Bacterial gastroenteritis generally produces more 
severe symptoms than viral infection, including more frequent and bloody stools and severe 
cramping. The importance of each pathogen depends on the region. In a study in 
Mozambique for example, diarrheagenic Escherichia coli (22%) were the most frequently 
isolated pathogens, followed by Ascaris lumbricoides (9.3%). Others detected pathogens 
included Salmonella spp. and Giardia lamblia (2.5% each) and Campylobacter spp. (1.7%). A. 
lumbricoides and Strongyloides stercolaris (100% versus 0%; P=0.008) were most frequently 
isolated in children older than 12 months of age (Mandomando et al., 2007).  
The prevalence of Cryptosporidium varies widely from country to country and from one 
region to another. In Korea, for example, Lee et al. (2005) reported a prevalence of 1% 
(among HIV patients) while in Tanzania, Houpt et al. (2005) described a prevalence of 17.3% 
amongst HIV patients. In Guinea Bissau, Cryptosporidium parvum had a prevalence of 7.7% 
and was the second most common parasite with a marked seasonal variation, with peak 
prevalence found consistently at the beginning of or just before the rainy seasons, May 
through July. In South Africa, studies by Kfir et al. (1995) indicated that Giardia cysts and 
Cryptosporidium oocysts were found in all types of water tested including surface water, 
sewage or treated effluents. Studies by Moodley et al. (1991) in Durban, South Africa 
showed that Cryptosporidium was the second most common enteric pathogen isolated from 
children admitted to hospital with gastroenteritis with infection rates varying between 1.2 
and 20.9% according to season with the highest prevalence in the summer months, and 10% 
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of the children infected with Cryptosporidium died. However the prevalence of 
Cryptosporidium infections is not known in Limpopo Province, and particularly in the 
Vhembe district. 
With the advent of HIV and AIDS, it has become more important to determine the 
distribution of parasitic infections such as E. histolytica and E. dispar amongst HIV infected 
individuals. In Mexico, E. histolytica prevalence of 25.3% in the HIV/AIDS group and 18.5% 
in the HIV negative group was described using PCR (Moran et al., 2005). Likewise in 
Taiwan, persons infected with HIV were at increased risk for invasive amoebiasis and 
exhibited a relatively high frequency of elevated antibody titers and intestinal colonization 
with E. histolytica (Hung et al., 2005). Previous studies in South Africa have been based in the 
Durban area in the eastern coast of the country where a prevalence of 10% using the PCR 
has been described (Zaki et al., 2003). However no study to our knowledge has been 
conducted in the Limpopo Province and particularly in the Vhembe district. The first case of 
human microsporidial infection was described in 1959 and as early as 2 years after the 
identification of HIV as the causative agent of AIDS, the microsporidial species 
Enterocytozoon bieneusi was discovered in HIV-infected patients with chronic diarrhea 
(Desportes et al., 1985). Although infections in immunocompetent patients are usually self-
limiting, infections in immune compromised host can be life threatening, especially in 
patients with AIDS (Desportes et al., 1985). Studies in Cape Town have indicated prevalence 
up to 22% of all Campylobacter spp when the filter method is used for isolation (Lastovica 
and Roux, 2000). In Venda, the infection level by Campylobacter spp was found to be around 
the same level (20%) amongst HIV infected individuals (Obi and Bessong, 2002). However, 
the isolates were not ascertained by the use of molecular methods and very few studies have 
determined the genetic variability of Campylobacter spp in Africa. Enteroaggregative 
Escherichia coli (EAEC) is an emerging diarrheagenic pathogen associated with diarrheal 
illnesses among patients in developed and developing countries. Recent studies have 
implicated EAEC in persistent diarrhea in patients infected with human immunodeficiency 
virus (HIV) (Wanke et al., 1998; Nataro et al., 2006).  
Clostridium difficile is a spore-forming, anaerobic Gram positive bacillus that produces 
exotoxins that are pathogenic to humans. Infection can lead to asymptomatic carriage or 
clinical disease, ranging from mild diarrhea to life threatening pseudomembranous colitis 
(Cleary, 1998). Clostridium difficile associated disease (CDAD) is an important clinical 
problem that is believed to occur predominantly following hospitalisation and 
administration of antibiotics and especially affects the elderly (Wilcox, 1996). Community-
acquired disease has been reported but the incidence is felt to be low and the rate of disease 
resulting in hospitalization is reported as negligible. For example a Swedish study of 5 133 
cases of C. difficile diarrhea defined 28% as being community acquired (Karlström et al., 
1998). Recent events in the USA, Canada and Europe have indicated the changing 
epidemiology of Clostridium difficile associated diarrhea (CDAD) with the occurrence of 
serious CDAD in otherwise healthy patients with minimal or no exposure to a health-care 
setting (Kuijper et al., 2006; Reichardt et al., 2007). However, the occurrence of C. difficile in 
developing regions such as the Vhembe district has not been reported. In the present study, 
molecular biology methods were used for the detection of different emerging bacterial and 
parasitic organisms including Campylobacter spp, Arcobacter spp, Enteroaggregative E. coli, 
Clostridium difficile, Cryptosporidium spp, Entamoeba histolytica and microsporidia, in relation 
to their pathogenicity among HIV positive and HIV negative individuals visiting different 
hospitals in the Vhembe district of South Africa.  
www.intechopen.com
Bacterial and Parasitic Agents of Infectious Diarrhoea 
in the Era of HIV and AIDS - The Case of a Semi Rural Community in South Africa 
 
149 
2. Material and methods 
2.1 Ethical Issues 
Ethical approval of this research was granted by the Health, safety and Research Ethics 
Committee of the University of Venda. Authorization was also sought and obtained from 
the Department of Health and Welfare Limpopo Province, South Africa. The different 
hospitals and schools were then approached and the research objectives thoroughly 
explained to the study participants in the local language (TshiVenda) for their consent. 
Informed consent was obtained from all participants either directly or through their legal 
and competent guardians. Only consenting individuals were accepted in the study.  
2.2 Study sites and sample collection 
The study was conducted in the Vhembe district, of the Vhembe district, Limpopo Province, 
South Africa. Thohoyandou, meaning "head of the elephant" in tshiVenda, is the former 
capital of the independent homeland and the proud heart of the VhaVenda people. 
Thohoyandou is home to the University of Venda and is also the headquarters of the 
Vhembe district and is the tenth most populated town in the country with 584,469 people 
while the population of the region is approximately 1.2 million. The Vhembe district is semi 
urban and agriculture is the main activity practiced by the population. Main hospitals in the 
region include Elim, Tshilidzini, Vhufhuli (Donald Frazer) and Siloam hospitals. These 
hospitals deliver care directly to the population and are referral centers for smaller clinics in 
the region.   The Vhembe district is bounded on the north by the Limpopo River, on the west 
by Sand River, on the south and east by the Levubu River and the remainder of the southern 
boundary by the farms adjoining the south of the Sinthumule location. The bulk of the 
people are today concentrated in locations and crown lands approximately from longitude 
29*40’E-30*50’E and latitude 22*20’S-23*10’S. In normal seasons the rain starts in 
October/November and from that time onwards the weather becomes moist and hot, the 
shade temperature ranging from 80-90 degrees and north of the mountains being 110 
degrees or more.  
For sample collection two groups of population were considered for the study including 
patients attending four main public hospitals in the region namely Elim, Vhufuli, Siloam 
and Tshilidzini hospitals, and pupils from two public primary schools both situated in 
Wuwani, locality situated at about 6km from the Tshilidzini hospital. At the primary 
schools, the objectives of the study were explained to the parents in a meeting with the 
authority of the schools who then distributed the collection bottles to the pupils whose 
parents had agreed to the study and signed a consent form. The pupils then brought the 
collection bottles home and with the help of their parents collected the stool in the bottles. 
The samples were collected the following morning from the schools and transported 
without any further delay to the Laboratory of Microbiology, University of Venda. Samples 
that were not analysed the same day were stored at -20oC. A total of 322 stool samples were 
collected. 255 samples were from patients attending the three public hospitals with 
abdominal complaints or diarrhea while 67 were from apparently healthy pupils attending 
two public primary schools. 
2.3 Lactoferrin latex agglutination assay 
Stool supernatants were tested according to the manufacturer’s specifications including 
appropriate kit controls (LEUKO-TEST; Tech Lab, Blacksburg, VA). Stool sample dilution 
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was conducted as described by the manufacturer in the following way: one drop (50 µl) of 
stool was added to 375 µl of diluent yielding a 1:25 dilution. Using the pipette provided 
with the Kit, one drop of the diluted sample was mixed with one drop of sensitized latex 
(lactoferrin antibody-coated latex beads) or negative latex beads for 3min and the 
agglutination was observed for positive samples. Each test was run in parallel with a 
negative control as indicated by the manufacturer. Positive controls provided with the test 
kits were also performed. Agglutination reaction was graded with the unaided eye from 0 
(no agglutination) to 4+ (large agglutination with a clear background). 
2.4 Lactoferrin quantitative assay 
The lactoferrin content in the lactoferrin positive stools samples was quantified using the 
ELISA method with the IBD scan kit from Techlab (Blacksburg, Virginia) following the 
instructions of the manufacturer. 
2.5 Test for occult blood 
The presence of occult blood in the stool samples was tested by the Hemoccult test kit 
(Beckman Coulter, Inc Harbor Blvd, Fullerton, CA, USA) following the instructions of the 
manufacturer.  
2.6 Detection of pathogenic organisms 
2.6.1 DNA purification 
Four different methods were used and compared for the purification of total genomic DNA 
from stool samples. This would then allow for the detection of most parasites from the same 
sample and avoid conducting several DNA extractions from the same samples for the 
molecular detection of different pathogens. The first method involved the treatment of 
200µg of stool sample by a freeze-thaw procedure using liquid nitrogen and boiling water 
followed by the use of the QIAamp DNA Stool Mini Kit from Qiagen (Valencia, CA, USA) 
according to the manufacturer’s recommendations. The second method involved the use of 
the QIAamp DNA Stool Mini Kit, with higher temperature (95oC) for the first incubation. 
The third method involved the used of alkaline treatment following a modified version of 
the method described by Haque et al., (1998). Briefly, fifty microliters of 1M KOH and 18 µl 
of 1M dithiothreitol were added to 250mg or 250 µl of stool. The samples were mixed 
thoroughly by stirring with a pipette tip, followed by brief shaking. After incubation at 65°C 
for 15 min, the samples were neutralized with 8 µl of 25% HCl and buffered with 80 µl of 2M 
Tris–HCl (pH 8.3) and the suspension was mixed by briefly vortexing. The genomic DNA 
was then purified from the suspension using the QIAamp DNA Stool Mini Kit from Qiagen 
(Valencia, CA, USA) following the manufacturer’s instructions. The last method was the use 
of glass beads in order to physically dreak open the cells, cysts, oocysts and spore that could 
be in the stool samples. Following the bead beating the QIA amp DNA Stool Mini Kit from 
Qiagen for final DNA purification.  
The comparison of all the pretreatment methods showed that a combination of two 
pretreatment methods including one which is either the bead beating or the alkaline 
treatment or freeze and thaw with a surplus stool portion added untreated and the whole 
used in the Qiagen with an increased temperature at 95oC for 15 min gave bettwe 
detectionof all pathogens including bacterial and parasites. The purified DNA was stored at 
-20oC until further used in the different PCR and Real time PCR procedures. 
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2.6.2 Detection and genotyping of Cryptosporidium 
Cryptosporidium species detection and genotyping was conducted as previously described 
using a real time PCR for the screening and PCR –RFLP for genotyping (Samie et al., 2006a). 
2.6.3 Detection and genetic characterisation of Entamoeba histolytica 
Entamoeba histolytica was detected from the samples using the Techlab (TechLab, Inc. 
Blacksburg, VA, USA) E. histolytica II antigen detection kit . The identification of the 
different species of Entamoeba mainly E. histolytica and E. dispar was conducted as previously 
described (Samie et al., 2006b). Genotyping of E. histolytica was conducted as previously 
described through the polymorphism of the serine-rich E. histolytica protein (SREHP) 
followed by enzymatic digestion (Samie et al., 2008).  
2.6.4 PCR amplification for the detection of microsporidia 
The PCR method described by Fedorko et al (1995) and further developed by Samie et al., 
(2007) was used with minor modification as indicated followed by restriction analysis.   
2.6.5 Detection of Campylobacters  
2.6.5.1 Culture and maintenance of reference strains 
Reference strains used in this study included Campylobacter jejuni subsp. jejuni (ATCC 
33291), Campylobacter coli (ATCC 33559) , Campylobacter concisus (ATCC 33237), Campylobacter 
fetus subsp. fetus (ATCC  27374), Campylobacter hyointestinalis (ATCC  35217), Campylobacter 
upsaliensis (ATCC  43954), Helicobacter pylori (ATCC  43504), Arcobacter butzleri (ATCC  49616), 
Campylobacter jejuni (ATCC 33560), Campylobacter jejuni (ATCC 81116), Campylobacter jejuni 
(ATCC  11168), Campylobacter coli (ATCC  33559) and Campylobacter lari (ATCC 35221). The 
cultures were sub-cultured in blood agar supplemented with 10% tryptose and 0.1% yeast 
extract and were preserved in Bolton broth and 25% sterile glycerol. Prior to DNA isolation, 
500 µl of the preserved culture was added to 10ml of brain Heart infusion or Bolton broth 
and incubated in a Microaerophilic environment for 24hours and inoculated to blood agar 
or mCCDA. The culture method using a charcoal based media (mCCDA) was used to detect 
Campylobacter spp from 37 diarrheal stool samples collected from Donald Frazer hospital as 
indicated in the Cape Town protocol (Lastovica and Le Roux, 2000) and suspected colonies 
were confirmed using a Campylobacter haemagglutination kit “Campy Dry Spot” (Oxoid, 
England) as recommended by the manufacturer. 
2.6.5.2 PCR detection of Campylobacteria 
The genomic DNA purified as described above was used for the detection of Campylobacter 
spp, Arcobacter spp and Helicobacter spp by the PCR- RFLP as described by Marshall et al 
(1999) and Samie et al., (2007a).  
Restriction profiles were generated with   DdeI, TaqI, or BsrI (New England Biolabs, Inc., 
Beverly, Mass.) in a 20-μl reaction mixture including 10 μl of the PCR amplicon with 10 U of 
the restriction endonuclease following conditions recommended by the manufacturer. Ten 
microliters of each digest was analyzed electrophoretically at 5 V/cm for 2 h with a 3% 
agarose gel in 1× TAE buffer. The gels were stained in ethidium bromide and photographs 
were taken for the analysis of the profiles. Further specific detection and confirmation of 
Campylobacter jejuni and coli was conducted as previously described (Linton et al., 1997; 
Samie al., 2007a)  
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Campylobacter concisus was detected from the samples using the method described by 
conventional and real time PCR protocols based on the methods previously described by 
Matsheka et al (2001).   
A real time PCR for the rapid detection of Campylobacter concisus was developed based on 
the method described by Matsheka et al. (2001) and Samie et al (2008) using the primers 
pcisus1 and pcisus6 and the iQTM SYBR® Green Supermix (Bio-Rad, CA),  
2.6.5.3 Specific detection of Helicobacter Pylori 
The specific detection of H. pylori was conducted as previously described (Samie et al., 
2007b) using the primers consisting of two specific 16S rRNA oligonucleotides, designated 
HPF and HPR, which generates a 138-bp product.  
2.6.5.4 Use of a multiplex PCR assay for the simultaneous detection and identification of 
Arcobacter butzleri, Arcobacter cryaerophilus and Arcobacter skirrowii 
A multiplex PCR reaction described by Houf et al (2000) and modified by Samie et al was 
used to identify the three main Arcobacter species.  
2.6.6 Detection of Enteroaggregative E. coli from stool samples 
A quantitative real time PCR using SYBR-Green -490 (Bio-Rad, CA) based on the protocol 
described by Samie et al., (2007c) used to confirm the presence of the AggR gene of EAEC in 
the stool samples. Standard cultures with known numbers of EAEC cells were used as 
reference and positive controls, while water and E. coli K-12 were used as negative controls 
in each reaction. The level of positivity of the samples was indicated by the Ct values. 
2.6.6.1 Multiplex PCR detection of EAEC virulence genes from stool samples 
A multiplex PCR protocol previously described was used with modifications in order to 
determine the presence of three EAEC genes in the stool samples (Cerna et al., 2003; Samie et 
al., 2007c). Only the presence of the correctly sized gene PCR product(s) was interpreted as a 
positive test.  
2.6.7 Detection of Clostridium difficile from stool samples 
A PCR protocol targeting a species-specific internal fragment of the triose phosphate 
isomerase (tpi) housekeeping gene was used as described by Lemee et al., (2004) for the 
detection of C. difficile in the stool samples (Samie et al., 2008c). The presence of the binary 
toxin was ascertained by two different reactions using two different primer pairs for the 
enzymatic and the binding components of the cdt gene using the conditions previously 
described by Stubbs et al., (2000). The negative regulator gene was detected by using two 
different primer pairs as previously described by Spigaglia and Mastrantonio (2002). The 
first primer pair (C1 and C2) detects a fragment of the tcdC gene while the second primer 
pair (Tim 1 and Struppi 2) amplifies and internal fragment of the first PCR product. The 
PCR products were observed in 2% agarose gel except for the products of the second PCR 
for the tcd gene that was run in 3% agarose gel. This helped to observe any size difference 
that could exist in the amplification products.  
2.7 Statistical analysis 
All data was analysed using the statistical package for social sciences (SPSS) program 
(Version 13.1). The potential relationship between the presence of the different pathogens 
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and the pathogenesis variables such as diarrhea, intestinal inflammation (through the 
measurement of the intestinal lactoferrin in the stool samples) and the presence of occult 
blood was determined by cross tabulation and the chi squarre test, risk evaluation and the 
Mantel-Haenszel Common Odds Ratio Estimate was used for statistical analysis. The 
difference was considered significant if the p value was less than 0.05.  The Pathogenicity 
index (PI) as well as the Inflammatory index (II) were calculated. These were the ratios of 
the number of samples that were diarrheal (for PI) or were positive for Lactoferrin (for II) 
and positive for the pathogen in consideration over the number of samples that were 
positive for the pathogen but not positive for lactoferrin or diarrhea. This indicates the 
strength of the involvement of the organisms in the specific pathogenicity (diarrhea or 
intestinal inflammation).   
3. Results 
3.1 Population demographics and characteristics of stool specimens 
From a total of 322 samples from 322 individuals of whom 44 were HIV positive patients 
while 211 were HIV negative patients and 67 were apparently healthy school children. The 
age of the hospital patients varied between 2 weeks and 88 years with most patients aged 
between 10 and 39 years old while the school children were aged between 3 and 15 years. At 
the hospital 148 (58%) were females while at the schools 34 (51%) were females. Diarrhea 
was common among hospital patients (65%) as well as intestinal inflammation indicated by 
elevated lactoferrin level in the stool samples (56%), and the presence of occult blood in the 
stools (43%).  Diarrhea was common in the age groups 0 – 2 and 2 – 5 yeas old, and also in 
the age groups 40 – 49 and > 60. Diarrhea was more common amongst the HIV positive 
group compared to the HIV negative (χ2= 12.452, p = 0.002 < 0.05). Of the 44 samples 
collected from HIV positive individuals, 11 (25%) were non diarrheal, 32 (72.7%) were 
diarrheal and 1 (2.3%) had bloody diarrhea. Of the 44 HIV positive patients 27 (61.4%) were 
females. HIV positive individuals were found at all age groups but the highest percentage 
was among those older than 20 years.  
3.2 Gender distribution of diarrheagenic organisms in the study population 
There was no significant difference in the distribution of the different pathogens tested in 
the present study according to gender, except for Campylobacter coli and H. pylori both of 
which were more common in males compared to females (Table 1a). C. parvum was more 
common among females while C. hominis was more common among males, however, the 
difference was not significant (Table 1b). For E. histolytica, 16% of the females had E. 
histolytica DNA with about 4% E. histolytica single infection and 13% mixed infections with 
E. dispar, while 12.2% had E. dispar DNA alone. Of the 109 stool samples from males, 16 
(14.7%) had E. histolytica with 2 (1.8%) E. histolytica alone and 14 (12.8%) mixed infections. 
Seven (6.4%) had E. dispar DNA alone. Campylobacter concisus was more common among 
females (although the difference was not statistically significant) unlike C. coli that was more 
common in males. Similarly, Cryptosporidium parvum was more common among males while 
C. hominis was more common among females. Enterocytozoon bieneusi and Entamoeba 
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 C. jejuni  C. coli C. concisus H. pylori A. butzleri A. skirrowii A cryaerophilus 
Females 19 (10.4%) 7 (3.8%) 7 (3.8%) 76 (41.8%) 10 (5.5%) 4 (2.2%) 7 (3.8%) 
Males 14 (10.0%) 14 (10%) 3 (2.1%) 75 (53.6%) 10 (7.1%) 2 (1.4%) 2 (1.4%) 
Sub-total 33 (10.2%) 21 (6.5%) 10 (3.1%) 151 (46.9%) 20 (6.3%) 6 (1.9%) 9 (2.8%) 
χ2, 0.017 4.915 0.763 4.434 0.369 0.256 1.702 
p value 0.897 0.027 0.382 0.035 0.544 0.613 0.192 
Table 1a. Distribution of diarrheagenic pathogens by gender.  
 
 C. parvum C. hominis E. bieneusi E. histolytica  C. difficile EAEC 
Females  6 (4.4%) 18 (13.3%) 23 (12.6%) 22 (16.3%) 27 (14.8%) 29 (15.9%)   
Males 2 (1.8%) 18 (16.5%) 13 (9.3%) 16 (14.7%) 18 (12.8%) 23 (16.4%) 
Sub-total 8 (3.3%) 36 (14.8%) 36 (%11.2) 38 (15.6%) 45 (14%) 52 (16.1%) 
χ2, 1.295 0.485 0.895 0.120 0.258 0014 
p value 0.255 0.486 0.344 0.729 0.612 0.905 
Table 1b.  
3.3 Age distribution of different pathogens in Vhembe according to sample origin 
In the population studied, all age groups were affected by infections. However, patients in 
the age group between 3 and 5 years were the most infected particularly with organisms like 
C. jejuni, H. pylori, A. butzleri and Enteroaggregative E. coli for the bacterial organisms as 
well as C. hominis and E. histolytica among the parasites (Table 2a and 2b). Other species of 
Arcobacter did not occur among patients less than 5 years of age. Cryptosporidium parvum did 
not occur among patients aged less than 10 years (Table 2b). For Cryptosporidium, the age 
group the most affected were 2–5 years old (28.6%) 30–39 years old (23.5%), and 40–49, and 
4 (27.7%). None of the samples from individuals aged >60 was positive for Cryptosporidium. 
For E. histolytica, the age groups most infected were 0 – 2 (33%) followed by the age group 20 
– 29 (27%).  E. bieneusi was also common among the patients aged between 3 and 5 years old. 
The prevalence of A. butzleri was lower in the older population compared to the younger 
populations. 
3.4 Diarrhea related pathogens in the studied population 
Of all the samples analyzed, 31% of diarrheal samples did not have any pathogen while 66% 
of the non diarrheal samples had no pathogens detected. Helicobacter pylori was the most 
commonly detected organisms using polymerase chain reaction from both diarrheal and 
non- diarrheal samples, However, the difference was not significant. Of the 10 bacterial 
organisms tested, C. jejuni, toxigenic C. difficile, Enteroaggregative E. coli and C. coli were the 
most commonly detected and associated with diarrhea among the patients in the total 
population. These organisms also had the highest pathogenic indexes indicating their 
potential involvement in diarrheal cases. Of the 4 parasitic organisms tested, E. histolytica 
and Cryptosporidium hominis were more common and statistically associated with diarrhea 
with pathogenic indexes of 8 for E. histolytica and 2.1 for C. hominis. The prevalence of the 
different organisms in both diarrheal and non diarrheal samples is shown in Table 3 below 
as well as the pathogenic indexes of the organisms. Briefly, C. jejuni was the most 
pathogenic bacterial organisms (in relation to diarrhea) while E. histolytica was the most 
diarrheagenic parasitic organism in this population.  
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Total C. jejuni C. coli C. concisus H. pylori A butzleri A. skirrowii A cryaerophilus 
Hospitals 0 – 2  18  2 (11.1%) 0 1 (5.5%) 9 (50%) 2(11.1%) 0 0 
3 – 5  16  3 (18.7%) 1 (6.2%) 0 9 (56.2%) 1 (6.2%) 0 0 
6 – 9  16  2 (12.5%) 0 0 8 (50%) 1 (6.2%) 0 0 
10 – 19  65  4 (6.2%) 3 (4.6%) 4 (6.1%) 29 (44.6%) 6 (9.2%) 1 (1.5%) 1 (1.5%) 
20 – 29  62  9 (14.5%) 7 (11.3%) 1 (1.6%) 26 (41.9%) 4 (6.5%) 2 (3.2%) 2 (3.2%) 
30 – 39 42  6 (14.3%) 1 (2.3%) 0 29 (69%) 4 (9.5%) 2 (4.8%) 4 (9.5%) 
40 – 49  18  4 (22.2%) 2 (11.1%) 1 (5.5%) 8 (44.4) 0 0 1 (5.5%) 
50 – 59  10  1 (10%) 2 (20%) 0 4 (40%) 0 0 0 
≥ 60 8  1 (12.5%) 2 (25%) 0 4 (50%) 1(12.5%) 0 1 (12.5%) 
Subtotal 255 32 (12.5%) 18 (7%) 7 (2.7%) 126(49.4%) 19(7.5%) 5 (2%) 9 (3.5%) 
Schools 3 – 5  5  0 0 1 (20%) 4 (80%) 0 0 0 
6 – 9  4  0 0 0 1 (25%) 0 0 0 
10 – 15  58  1 (1.7%) 3 (5.2%) 2 (3.4%) 32 (55.2%) 1 (1.7%) 1 (1.7%) 0 
Subtotal 67 1 (1.5%) 3 (4.4%) 3 (4.5%) 37 (55.2%) 1 (1.5%) 1 (1.5%) 0 
Total  322 33 (10.2%) 21 (6.5%) 10 (3.1%) 163 (50.6%) 20 (6.2%) 6 (1.9%) 9 (2.8%) 
χ2   7.052 0.580 0.871 0.717 4.853 0.064 2.433 





Total C. parvum C. hominis E. bieneusi E. histolytica C. diff EAEC 
Hospitals 
0 – 2  18   1 (9.1%)  3 (27.3%) 3 (16.7%) 1 (5.6%) 
3 – 5  16   4 (28.6%) 4 (25.0%) 4 (28.6%) 2 (12.5%) 5 (31.3%) 
6 – 9  16   2 (15.4%)  2 (15.4%) 1 (6.3%) 2 (12.5%) 
10 – 19  65  2 (4.3%) 5 (10.6%) 6 (9.2%) 6 (12.8%) 10 (15.4%) 11 (16.9%) 
20 – 29  62  1 (2.1%) 7 (14.6%) 11 (17.7%) 13 (27.1%) 11 (17.7%) 12 (19.4%) 
30 – 39  42  5 (14.7%) 3 (8.8%) 9 (21.4%) 5 (14.7%) 12 (28.6%) 11 (26.2%) 
40 – 49  18   2 (13.3%) 2 (11.1%) 3 (20.0%) 1 (5.6%) 5 (27.8%) 
50 – 59  10   4 (50.0%)   2 (20.0%) 3 (30.0%) 
≥ 60 8    1 (12.5%) 1 (14.3%) 1 (12.5%)  
Subtotal 255 8 (4.1%) 28 (14.2%) 33 (12.9%) 37 (18.8%) 43 (17%) 50 (19.6%) 
Schools 
3 – 5  5   2 (50.0%)    2 (40.0%) 
6 – 9  4        
10 – 15  58   6 (14.6%) 3 (5.2%) 1 (2.4%) 2 (3.4%)  
Subtotal 67  8 (17.0%) 3 (4.5%) 1 (2.1%) 2 (3.0%) 2 (3.0%) 
Total  322   36 (11.2%) 38 (15.6%) 45 (13.9%) 52 (16.1%) 
χ2         
P value         
Table 2b. 
Table 2 Distribution of bacterial and parasitic agents of diarrhea in the study population 
according to age group. 
3.5 Diarrheagenic organisms and intestinal inflammation 
Intestinal inflammation was measured by the amount of lactoferrin produced in the stool 
samples. Previous studies have correlated the occurrence of lactoferrin in the stool samples 
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with leukocytes which is a marker of intestinal inflammation and even better because fecal 
leukocytes are generally difficult to count since they die faster once out of the body. 
Therefore, fecal lactoferrin is the best marker of intestinal inflammation. The inflammatory 
index was calculated in the same manner as the pathogenic index by dividing the 
prevalence of the organisms in lactoferrin positive samples by that of the organisms in 
lactoferrin negative samples. Of all the bacterial organisms tested Campylobacter jejuni was 
the most significantly associated with intestinal inflammation. Enteroaggregative E. coli was 
the next most inflammatory bacterial organism followed by C. coli and C. concisus (Table 4). 
Of all the parasitic organisms tested in the present study, E. histolytica was significantly 






Total χ2, p value PI 
No Infection 53 (31.2%) 101 (66.4%) 154 (47.8%)   
All infections      
C. jejuni 29 (17.1%) 4 (2.6%) 33 (10.2%) 18.159 (0.000) 6.6 
C. coli 16 (9.4%) 5 (3.3%) 21 (6.5%) 4.934 (0.026) 2.8 
C. concisus 8 (4.5%)  2 (1.4%) 10 (3.1%) 1.226(0.268) 3.2 
A. butzleri 14 (8.2%) 6 (3.9%) 20 (6.2%) 2.533 (0.112) 2.1 
A. skirrowii 3 (1.8%) 3 (2.0%) 6 (1.9%) 0.019 (0.890) 0.9 
A. cryaerophilus 4 (2.4%) 5 (3.3%) 9 (2.8%) 0.259 (0.611) 0.7 
H. pylori 91 (51.7%) 60 (41.1%) 151 (46.9%) 2.652(0.103) 1.2 
C. diff 34 (19.3%) 11 (7.5%) 45 (13.9%) 9.21 (0.002) 2.6 
Toxigenic C. diff 20 (11.4%) 3 (2.1%) 23 (7.1%) 10.48 (0.001) 5.4 
Non Toxigenic C. 
diff 
14 (8%) 8 (5.5%) 22 (6.8%) 0.768 (0.381) 1.4 
EAEC 36 (21.2%) 16 (10.5%) 52 (16.1%) 6.722 (0.010) 2.01 
Parasitic organisms      
E. histolytica 34 (27%) 4 (3.4%) 38 (15.6%) 25.544 (0.000) 8 
C. parvum 4 (3.2%) 4 (3.4%) 8 (3.3%) 0.009 (0.925) 1 
C. hominis 25 (19.8%)  11 (9.3%) 36 (14.8%) 5.361 (0.021) 2.1 
E. bieneusi 23 (13.1%) 13 (8.9%) 36 (11.2%) 1.393 (0.238) 1.5 
Table 3. Prevalence of different diarrheagenic pathogens in diarrheal and non diarrheal stool 
samples in the general population in the Vhembe district of South Africa as detected by 
different Polymerase Chain Reaction methods. The pathogenic indexes show the potential 
association of the organisms with diarrhea. 
3.6 Occurrence of organisms and occult blood in the stool samples 
Occult blood was tested in the samples and correlated with the presence of the different 
organisms. Of all the organisms tested, 4 bacterial species were significantly associated with 
occult blood and these included in order of statistical importance Enteroaggregative E. coli, 
Campylobacter jejuni, C. difficile and Campylobacter coli. Of all the parasitic organisms tested, 
only Entamoeba histolytica showed a statistically significant correlation with occult blood. The 
pathogenicity index in terms of occult blood occurrence in the stool samples in association 
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n negative  
stools  
Total χ2, p value OR (95%CI) II 
All infections       
C. jejuni 26 (17.4%) 7 (4.0%) 33 (10.2%) 16.586 (0.000) 5.231 (2.2 – 12.4) 4.4 
C. coli 14 (9.6%) 7 (4.0%) 21 (6.5%) 4.122 (0.042) 2.561 (1 – 6.5) 2.4 
C. concisus 8 (5.5%) 2 (1.1%) 10 (3.1%) 5.002 (0.025) 5.043 (1 – 24.1) 5 
A. butzleri 11 (7.5%) 9 (5.1%) 20 (6.2%) 0.803 (0.370) 1.5 (0.6 – 3.7) 1.5 
A. skirrowii 2 (1.4%) 4 (2.3%) 6 (1.9%) 0.356 (0.551) 0.597 (0.1 – 3.3) 0.6 
A. cryaerophilus 3 (2.1%) 6 (3.4%) 9 (2.8%) 0.539 (0.463) 0.594 (0.1 – 2.4) 0.6 
H. pylori 69 (47.3%) 82 (46.6%) 151 (46.9%) 0.014 (0.905) 1.027 (0.6 - 15) 1.01 
C. diff 25 (17.1%) 23 (13.1%) 48 (14.9%)    
EAEC 32 (21.9%) 20 (11.4%) 52 (16.1%) 6.565 (0.010) 2.189 (1.2 – 4) 1.9 
       
E. histolytica 27 (26%) 11 (7.9%) 38 (15.6%) 14.875 (0.000) 4.112 (1.9 – 8.7) 3.3 
C. parvum 3 (2.9%) 5 (3.6%) 8 (3.3%) 0.089 (0.766) 0.802 (0.2 – 3.4) 0.8 
C. hominis 18 (17.3%) 18 (12.9%) 36 (14.8%) 0.940 (0.332) 1.419 (0.6 – 2.8) 1.3 
E. bieneusi 16 (11%) 20 (11.4%) 36 (11.2%) 0.013 (0.909) 0.960 (0.4 – 1.9) 1 
Table 4. Diarrheagenic organisms and intestinal inflammation as indicated by the detection 
of lactoferrin in the stool samples. 
with the organisms was calculated using the same formula described above for lactoferrin 
and diarrhea. EAEC had the highest index followed by Campylobacter jejuni, Campylobacter 
coli and Clostridium difficile for the bacteria and E. histolytica among the parasites. The 
summary of these results is shown in table 4. EAEC infections were significantly associated 
with intestinal inflammation (χ2=6.565, P=0.010) and 61.5% of stools that were positive for 
EAEC genes had elevated lactoferrin compared to 42.2% for samples negative for EAEC 
genes. Stool samples positive for EAEC genes were more likely to have occult blood (Odd 
ratio=5.069; 95%CI: 2.665 – 9.644) even when the number of cells carrying the AggR gene 
was lower in the stool. Of the samples positive for at least one EAEC gene, 69.2% had occult 
blood compared to only 30.7% for samples negative for EAEC genes (χ2=27.725, P<0.00001). 
The occult blood pathogenicity index was higher for samples containing AggR compared to 
the other two genes. In general, most bacterial and parasitic organisms tested were more 
common in samples with occult blood. However, the difference was not significant (P>0.05) 
(Table 5). 
3.7 Occurrence of infections in HIV positive and HIV negative patients with or without 
diarrhea 
In the present study, the presence of bacterial and parasitic organisms was determined 
according to HIV status of the patients. In order to have a better indication on how 
important could a pathogen be to the HIV positive group, we calculated the HIV relatedness 
index (HI) by dividing the prevalence of these infections in HIV positive by the prevalence 
of the same organism among HIV negative patients. A higher HI indicates that the organism 

















Total χ2, p value OR (95%CI) PI 
All infections       
C. jejuni 21 (17.6%) 12 (5.9%) 33 (10.2%) 11.233 (0.001) 3.411 (1.6 – 7.2) 2.9 
C. coli 2 (10.1%) 9 (4.4%) 21 (6.5%) 3.929 (0.047) 2.417 (0.9 – 5.9) 2.3 
C. concisus 6 (5.0%) 4 (2.0%) 10 (3.1%) 2.35 (0.125)  2.642 (0.7 – 9.5) 2.5 
A. butzleri 10 (8.4%) 10 (4.9%) 20 (6.2%) 1.557 (0.212) 1.771 (0.7 – 4.3) 1.7 
A. skirrowii 2 (1.7%) 4 (2.0%) 6 (1.9%) 0.034 (0.853) 0.850 (0.1 – 4.7) 0.85 
A. cryaerophilus 5 (4.2%) 4 (2.0%) 9 (2.8%) 1.275 (0.241) 2.182 (0.5 – 8.2) 2.1 
H. pylori 58 (48.7%) 93 (45.8%) 151 
46.9(%) 
0.258 (0.611) 1.125 (0.7 – 1.7) 1.06 
C. diff 26 (21.8%) 22 (10.8%) 48 (14.9%) 7.171 (0.007) 2.300 (1.2 – 4.2) 2.01 
EAEC 36 (30.3%) 16 (7.9%) 52 (16.1%) 27.725 (0.000) 5.069 (2.7 – 9.6) 3.8 
       
E. histolytica 21 (23.3%) 17 (11%) 38 (15.6%) 6.530 (0.011) 2.453 (1.2 – 4.9) 2.1 
C. parvum 4 (4.4%) 4 (2.6%) 8 (3.3%) 0.611 (0.434) 1.7 (0.7 – 4.1) 1.7 
C. hominis 17 (18.9%) 19 (12.3%) 36 (14.8%) 1.938 (0.164) 1.655 (0.8 – 3.4) 1.5 
E. bieneusi 18 (15.1%) 18 (8.9%) 36 (11.2%) 2.960 (0.085) 1.832 (0.9 – 3.6) 1.7 
Table 5. Diarrheagenic organisms and occult blood in the stool samples. 
indication that the specific pathogen was correlated with HIV infections.  Of all the 
organisms tested in the present study, EAEC, C. jejuni and C. coli appeared to be important 
bacterial pathogens in HIV positive patients while E. bieneusi was the most common 
parasitic organism among HIV positive patients.  
The prevalence of EAEC infection among HIV positive individuals was significantly higher 
(χ2=5.360, P=0.021) with 13 (29.5%) infections than the rest of the study population with 39 
(14%) infections. Of the HIV positive patients tested, 8 were positive for E. histolytica. Of 
these individuals 5 were females and three were males. Among the HIV negative 
individuals, 29 (13.8%) males and 28 (13.3%) females were infected (χ2=0.754, P= 0.385). Five 
samples from HIV positive patients were genotyped for E. histolytica. Of these, 3 (60%) 
belonged to the same profile mostly (3 out of 4 [75%]) found in HIV positive patients with 
diarrhea (2 out of 3) or without diarrhea (1 out of 3). One other profile was found mostly (7 
out of 8) in HIV negative patients while one other profile was unique to a HIV positive 
individual. In the present study, we found a higher Campylobacter infection rate: 18.2% and 
11.4% among HIV positive patients compared to 11.4% and 6.2% in HIV negative 
individuals for C. jejuni and C. coli respectively. The prevalence of these Campylobacter’s 
infection among HIV positive individuals was significantly higher (χ2=5.360, P=0.021) with 
13 (29.5%) infections than the rest of the study population with 39 (14%) infections. When 
compared to HIV negative individuals, HIV positive individuals were more likely to have 
microsporidiosis (χ2=4.414, p=0.036).  In the HIV negative population, males were more 
infected than females. However, in the HIV positive population, females were significantly 
more infected than males (p<0.001). In the HIV negative subgroup, E. bieneusi was more 
www.intechopen.com
Bacterial and Parasitic Agents of Infectious Diarrhoea 
in the Era of HIV and AIDS - The Case of a Semi Rural Community in South Africa 
 
159 
common in individuals without diarrhea (15.9%) than individuals with diarrhea (9.0%), but 
this was not statistically significant. In the HIV positive group, E. bieneusi was found only in 
diarrheal samples indicating the possible involvement of these organisms in the production 
of diarrhea in immunocompromised hosts. The prevalence of infection by C. difficile was 
generally higher in HIV negative individuals (14.4%) than HIV positive individuals (11.4%), 
but the difference was not significant (χ2=0.289, p=0.591). However, all the toxigenic C. 
difficile in HIV positive patients were found in diarrheal samples, with elevated lactoferrin 
and occult blood while the non-toxigenic strains were found in stool samples negative for 
the lactoferrin test and for occult blood indicating that even though C. difficile infections are 
not more prevalent among HIV positive patients, they might be more susceptible to these 
infections. 
 
  C. jejuni C. coli C. concisus H. pylori A butzleri A. skirrowii A cryaerophilus 
HIV 
positive 
Diarrheal 8 (21.1%) 5 (13.2%) 2 (5.3%) 19 (50%) 1 (2.6%) 1 (2.6%) 2 (5.3%) 
Non 
diarrheal 
0 0 0 3 (50%) 0 0 0 
Sub-total 8 (18.2%) 5 (11.4%) 2 (4.5%) 22 (50%) 1 (2.3%) 1 (2.3%) 2 (4.5%) 
        
HIV 
negative 
Diarrheal 21 (15.9%) 12 (9.1%) 6 (4.5%) 68 (51.5%) 13 (9.8%) 2 (1.5%) 3 (2.3%) 
Non 
diarrheal 
4 (2.7%) 4 (2.7%) 2 (1.4%) 61 (41.8%) 6 (4.1%) 3 (2.1%) 4 (2.7%) 
Sub-total 25 (9%) 16 (5.8%) 8 (2.9%) 129 (46.4%) 19 (6.8%) 5 (1.8%) 7 (2.5%) 
         














 PI 2 2 1.5 1.1 0.3 1.3 1.8 
Table 6a 
 
  C. parvum C. hominis E. bieneusi E. histolytica C. difficile EAEC 
HIV 
positive  
Diarrheal 1 (3.8%) 3 (11.5%) 9 (23.7%) 4 (15.4%) 5 (13.2%) 12 (31.6%) 
Non 
diarrheal 
0 0 0 1 (16.7%) 0 1 (16.7%) 
Sub-total 1 (3.1%) 3 (9.4%) 9 (20.5%) 5 (15.6%) 5 (11.4%) 13 (29.5%) 
       
HIV 
negative 
Diarrheal 2 (2.1%) 19 (20.2%) 13 (9.8%) 30 (31.9%) 28 (20.3%) 25 (18.9%) 
Non 
diarrheal 
5 (4.2%) 14 (11.9%) 14 (9.6%) 3 (2.5%) 12 (8.6%) 14 (9.6%) 
Sub-total 7 (3.3%) 33 (15.6%) 27 (9.7%) 33 (15.6%) 40 (14.4%) 39 (14.0%) 
        












 PI 1 0.6 2.1 1 0.8 2.1 
Table 6b. 
Table 6. Distribution of bacterial and parasitic organisms among HIV positive and HIV 
negative patients. The statistics compare the values for the HIV positive and the HIV 
negative patients. The HIV relatedness index (HI) was the ratio of the occurrence of 
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4. Discussion  
Intestinal bacterial and parasitic infections are common in developing countries and 
responsible for most acute and chronic diarrhea cases amongst HIV/AIDS patients (Silva et 
al., 2010). The objective of this study was to determine the prevalence and genotype 
distribution of bacterial and parasitic organisms in the general population including school 
children and among HIV positive and HIV negative individuals in the Vhembe district of 
South Africa; a semi urban area situated in Limpopo Province in the northern part of the 
country. The organisms detected include Cryptosporidium species, Entamoeba histolytica, 
Microsporidia, Campylobacter spp, Arcobacter spp, Helicobacter pylori, Emteroaggregative E. 
coli and Clostridium difficile.  
According to the South African Department of Health, the HIV prevalence in the general 
population was 10.8% for all South Africans over the age of 2 years in 2005 (DOH, 2010). 
Among those between 15 and 49 years old, the estimated HIV prevalence was 16.2% in 2005. 
Females were more affected (13.3%) than males (8.2%). In the Limpopo Province, the 
prevalence in the whole population was 8%. In our study, 15.7% of the patients visiting the 
hospitals were positive for HIV. This is closer to the national prevalence for individuals 
between 15 and 49 years of age. These rates are still high compared to countries from other 
parts of the African continent such as Mali (1.9%), but is comparable with the rates in other 
countries in the Southern African sub-region such as Malawi (14.2%) and Zambia (16.5%) 
(Banerjee et al., 2004). It is well known that chronic diarrhea is one of the major AIDS-
defining illnesses in WHO Classification and occurs in 60-90% of HIV infected patients in 
Africa and in a Swiss Cohort Study, diarrhea was found to be an independent predictor of 
poor survival amongst HIV and AIDS patients (Tadesse and Kassu, 2005; Humphreys et al., 
2010). In our study, diarrhea was very common and was present in 74.2% of fecal specimens 
submitted from cases in the HIV population and is thus in agreement with data from 
previous studies.  
Studies in other parts of the world have indicated that Cryptosporium spp represented by C. 
Parvum are the most common diarrheagenic parasitic organisms, however, few studies have 
compared rates among HIV negative and HIV positive patients.  The prevalence and species 
distribution of Cryptosporidium spp vary greatly with the regions or country studied and 
even within specific groups of the population. This creates a complex picture of the 
epidemiology of infection by these organisms whose understanding will be helpful in 
shaping the appropriate measures for their control. In Limpopo Province, the HIV 
prevalence is 16.2% as determined by the report of the Department of Health and Welfare of 
South Africa (DOH, 2003). Previous studies in Limpopo Province have targeted different 
bacterial infections in HIV/AIDS patients; however no attempt has been made to isolate 
parasites (Obi and Bessong, 2002). This study is thus the first to use a molecular approach 
for the detection, genetic diversity and pathogenicity of the bacterial and parasitic infections 
in the region. 
The real time quantitative PCR (qPCR) is a very sensitive, specific and easy to use method 
for the identification and quantification of organisms from a variety of sources. The qPCR 
used in the present study for the detection of Cryptosporidium has been tested for specificity 
and sensitivity using stools spiked with different numbers of oocysts and proved to be 
highly effective (Houpt et al., 2005; Taniuchi et al 2011). Studies in various tropical countries 
have demonstrated highest prevalence of cryptosporidiosis in children younger than 2 
years. In rural areas children of between 2 – 5 years old are more exposed to infections since 
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this is the period when they begin to be active on their own. In Zimbabwe, Simango and 
Mutikani (2004) demonstrated that Cryptosporidium was common amongst children aged 
less than 5 years old with infection rate of 11.2%. In India, studies conducted in twin cities of 
Hyderabad and Secunderabad indicated that children in the age group of six months to one 
year were the most vulnerable with 14.3% infections compared to 8.2% among children less 
than five years of age while in Malaysia the prevalence was 7.5% and 33.3% in Egypt 
(Nagamani et al., 2007; Al-Mekhlafi et al., 2011). 
It has been demonstrated in some countries such as Mexico (Javier-Enriquez et al., 1997), 
Brazil (Newman et al., 1999; de Oliveira-Silva et al 2007), and Indonesia (Katsumata et al., 
2000; Moyo et al., 2011) that Cryptosporidium transmission in children is usually associated 
with the rainy season, and waterborne transmission is considered a major route in the 
epidemiology of cryptosporidiosis in these areas. Although water contamination with 
Cryptosporidium has been demonstrated in other parts of South Africa, such research needs 
to be completed in the Limpopo Province in order to confirm the source of transmission in 
the region. Considering the presence of Cryptosporidium in the hospitals as well as in the 
schools, it can be hypothesized that water is a widespread transmission vector in the region. 
A study in Peruvian children has demonstrated that cryptosporidiosis was more frequent in 
children from houses without a latrine or toilet (Bern et al., 2002). Previous studies in Venda 
have also indicated poor level of hygiene in Venda (Potgieter et al., 2005). However, more 
detailed studies need to be conducted in order to clarify the role of hygienic habits in the 
transmission of Cryptosporidium as well as other parasitic organisms in the Vhembe district. 
Cryptosporidium parasitizes the small intestinal epithelium. Infection results in accelerated 
loss of villous enterocytes, leading to severe villous atrophy and a malabsorptive and 
secretory diarrhea. The most common symptom of cryptosporidiosis is watery diarrhea. 
Other symptoms include: dehydration, weight loss, stomach cramps or pain, fever, nausea, 
and vomiting. Abdel-Messih et al. (2005) in Egypt demonstrated that clinical findings 
associated with Cryptosporidium diarrhea included vomiting, persistent diarrhea and the 
need for hospitalization. Studies by Alcantara et al. (2003) indicated that Cryptosporidium was 
associated with inflammation as indicated by the lactoferrin test and the presence of IL8 and 
TNF-. In this study, Cryptosporidium was also associated with inflammation and more than 
59.1% of Cryptosporidium infections might lead to inflammation. However more detailed 
study is required to clarify the real impact of Cryptosporidium infections as well as other 
protozoan parasitic infections in the production of intestinal inflammation in Venda. 
Another study in Haiti by Kirkpatrick et al. (2002) indicated that malnourished children with 
acute cryptosporidiosis mount inflammatory (with high lactoferrin content), Th-2, and 
counter regulatory intestinal immune responses. Studies of Peruvian as well as Brazilian 
children have demonstrated malnutrition, particularly stunting with lack of growth catch-
up after even asymptomatic C. parvum infection (Checkley et al., 1998; Antonios et al., 2010). 
The existence of two Entamoeba species morphologically identical but genetically different 
was suggested as early as 1925 by Brumpt. However, it was not until 1993 that enough 
biochemical, immunological and genetic data were gathered to re-classify E. histolytica into 2 
separate species: E. histolytica which can invade the gut mucosa, causes diarrhea and extra-
intestinal disease, and E. dispar, which causes only asymptomatic colonization (Diamond 
and Clark, 1993). Following the reclassification of Entamoeba histolytica, the epidemiology of 
amoebiasis needed to be redefined by the use of methods that are able to differentiate 
between E. histolytica and E. dispar. Thus different PCR methods have been developed with 
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variable efficiencies. A nested PCR previously described has been successfully used to 
differentiate between E. histolytica and E. dispar (Haque et al, 1998; Ali et al., 2003). Using the 
same method; we were able to differentiate between E. histolytica from E. dispar in samples 
collected from patients visiting public hospitals with gastrointestinal complaints or diarrhea; 
and pupils attending public primary schools in the Vhembe district. E. histolytica was found 
both in the hospital and in the Schools. However, E. histolytica was less common amongst 
primary School children aged between five and fifteen. These findings underscore the 
potential role of E. histolytica in morbidity in the study area since the association between E. 
histolytica infections and diarrhea was statistically significant (P < 0.05). Similar results have 
been found in other countries around the world such as Thailand (Haghighi et al., 2003). 
Infection rates as well as species diversity (ratio between the occurrence of E. histolytica and 
E. dispar) varied tremendously from one region to the other. In Italy, more patients were 
found to be infected with E. dispar (8.3%) than E. histolytica (5.6%) using PCR assays 
(Calderaro et al., 2005). In Sweden, amoebiasis is a notifiable disease and 400–500 cases are 
reported annually to the Swedish Institute for Infectious Disease Control (SMI). The PCR 
analysis showed that 165 (79.7%) patients were positive for E. dispar, whereas only 10 (4.8%) 
patients were positive for E. histolytica (Lebbad and Svard, 2005). In contrast, higher rates of 
E. histolytica infections was found in Mexico as compared to E. dispar infections (13.8% 
versus 9.6%), using PCR (Ramos et al., 2005). Similarly in the Philippines, 74 cases (65.48%) 
were positive for E. histolytica and 6 cases (5.30%) positive for E. dispar from a mental 
institution (Rivera et al., 2006). In the Gaza strip, Palestine, E. histolytica was identified by 
PCR in 64 (69.6%) of the samples and that of E. dispar in 21 (22.8%) (Al-Hindi et al., 2005). 
In the present study, we found a rate of 15.5% for E. histolytica which is higher than the rate 
found in Durban by Gathiram and Jackson (1985). This can be explained by the fact that our 
population was potentially ill and thus had a higher risk of been infected which was not the 
case in the group without diarrhea in whom there were no mixed infections and only one 
asymptomatic case of E. histolytica was found. The antigen detection test from Techlab 
(Blacksburg, Virginia, USA) has previously been shown to be suitable for the diagnosis of 
amoebiasis in endemic areas (Abd-Alla and Ravdin, 2002). In the present study, ELISA had 
a high specificity. It should be noted that samples positive for PCR and negative with the 
ELISA test were generally mixed infections with E. histolytica and E. dispar. This might have 
a hindering effect on the ability of the ELISA test to detect these samples and might also be 
related to the pathogenicity or virulence of the strains involved. It has been indicated 
elsewhere that when both organisms are present in an individual, E. dispar generally 
outgrows E. histolytica. However, since E. dispar is non pathogenic, the result of the infection 
will probably be asymptomatic. Mixed infections have also been described in Mexico where 
13% of individuals were found harboring E. histolytica and E. dispar at the same time, 
particularly amongst HIV positive individuals (Moran et al., 2005). 
The mechanisms of disease production following an infection by E. histolytica are not fully 
understood. Most E. histolytica infections remain asymptomatic. However, other studies 
have suggested that amebic colitis may be encountered during colonoscopic examination 
even in subjects who are asymptomatic (Okamoto et al., 2005). E. histolytica has also been 
associated with traveler’s diarrhea. In a study in Sweden, when the patients were divided 
into immigrants and travelers, the percentages with E. histolytica were 3.8% and 9.5%, 
respectively (Barwick et al., 2002). In invasive amoebiasis, white blood cells can be present in 
the stool, and in severe cases pus can be visible, but faecal leukocyte numbers are generally 
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not as high as in shigellosis (Speelman et al., 1984). Indeed, virulent E. histolytica can destroy 
neutrophils upon contact; hence may induce inflammation but show only pyknotic 
leukocytes in the stools (Guerrant et al., 1981; Callendar, 1933). Such a process would be 
expected to cause evidence of inflammation (i.e. lactoferrin) even without morphologically 
clear PMNs in the stool. Inflammation occurs most often and previous studies have 
demonstrated that fecal lactoferrin was the best way to indicate the presence of PMN in 
stool samples. In our study, 85.7% of samples with E. histolytica DNA were positive for 
lactoferrin with 43% of cases presenting with high level of lactoferrin while E. dispar positive 
samples had only 1 (4.3%) case with a high lactoferrin level. This further confirms the 
pathogenic differences between the two species. When we excluded other detected 
organisms, the association of E. histolytica with diarrhea and with lactoferrin was even 
stronger. Other studies had indicated low levels of lactoferrin with E. histolytica and S. 
hematobium infections compared to shigellosis and other UTI infections (Aly et al., 2005). 
However, E. histolytica infections had not been ascertained by specific test such as PCR. 
Whether risk of invasive amebiasis due to E. histolytica is higher among human 
immunodeficiency virus (HIV)-infected persons than uninfected persons remains unclear, 
although intestinal colonization by E. histolytica/dispar has been reported to be higher among 
HIV positive individuals (Moran et al., 2005). While studies in Thailand have indicated that 
E. histolytica was more common among HIV positive patients (P<0.001), studies in Mexico 
were not conclusive on this issue (Hung et al., 2005). We had recently described a much 
higher seroprevalence of Entamoeba histolytica among HIV and AIDS patients compared to 
HIV negative patients (Samie et al., 2010). In  a study on the genetic diversity of E. histolytica,  
we found that one profile was more common among HIV positive individuals indicating 
that the increased susceptibility of HIV positive individual to E. histolytica might depend on 
the genetic profile of the infecting E. histolytica strain. In a recent study in Uzbekistan, HIV-
infected patients were found to have virtually all parasites, such as Giardia lamblia, 
Cryptosporidium parvum, Chilomastix mesnili, Entamoeba coli, Iodamoeba butschlii, Entamoeba 
histolytica/dispar, Endolimax nana, Blastocystis hominis, Enlerobius vermicularis, Ascaris 
lumbricoides, Hymenolepis nana, detectable in the population of Tashkent (Nurtaev et al., 
2006). Of special interest was the fact that in all the forms (stages) of HIV infection, the 
infestation with E. histolytical/dispar was 10 times greater than that in non HIV infected 
individuals.    
Since their successful isolation from stools in the 1970s Campylobacter spp have risen from 
obscurity to notoriety as important food borne agents of gastroenteritis with present 
isolation rates superceding those of other enteric pathogens such as Salmonella spp. and 
Shigella spp. in most developed countries and higher prevalence among children in the 
developing world (Crushell et al., 2004; Fernández-Cruz et al., 2010). Although their 
implication in human infections has been described worldwide, their epidemiology varies in 
different regions of the world and the knowledge of their prevalence using molecular 
methods is essential for the designing of efficient control measures adapted to each area. 
Acute self-limited gastrointestinal illness, characterized by diarrhea, fever and abdominal 
cramps, is the most common presentation of C. jejuni/C. coli infection (Butzler, 2004). In this 
study we found a significant association of C. jejuni and C. coli infections with diarrhea and 
inflammation.  Campylobacter spp other than C jejuni/coli have also been implicated in human 
and animal diseases (Lastovica and Skirrow, 2000; Moran, 2010). In this study, we detected 
C. concisus in 10 (3.1%) samples with 6 (60%) cases present in diarrheal stools indicating the 
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possibility of the involvement of this Campylobacter species in disease production in the 
Vhembe district. In Cape Town, studies by Lastovica and LeRoux indicated that C. concisus 
was the second most isolated Campylobacter after C. jejuni and constituted 23.55% of all 
Campylobacter isolates (Lastovica and Le Roux, 2000).  
Unlike its close phenotypically related neighbour Campylobacter, Arcobacter is not currently a 
major public health concern, but is considered as an emerging human pathogen, and is of 
significance in animal health (Snelling et al., 2006; Kalischuk and Buret, 2010). In the present 
study 70% of A. butzleri containing samples was diarrheal and 55% with elevated level of 
lactoferrin indicating possible involvement in inflammatory processes. However more 
research needs to be conducted in order to confirm its involvement in human disease. H. 
pylori was found in 163 (50.6%) of all the samples among which 55.9% of H. pylori positive 
samples were diarrheal  and that Helicobacter pylori was common among school children and 
hospital patients. These results are similar to previous studies that have indicated that H. 
pylori is a common human pathogen estimated to colonize 50% of the world's population 
(Van Der Hulst et al., 1996). Epidemiological evidence has suggested that H. pylori is spread 
by fecal-oral and oral-oral routes. Although there are no known environmental reservoirs 
for H. pylori, H. pylori has been cultured from the feces (Thomas  et al., 1992) of infected 
individuals and has been detected by polymerase chain reaction (PCR) in dental plaque 
(Nguyen et al., 1993). The prevalence found in the present study was lower compared to 
other recent studies in Pretoria, South Africa, where H. pylori was found in 84% of stomach 
biopsies from Healthy individuals but not in dental samples (Olivier et al., 2006). It has been 
estimated that the relationship between chronic diarrhea, retarded growth, iron-deficient 
anaemia, and H. pylori infection in children especially from developing countries remains 
controversial (Raymond et al., 2005). However, more research is needed in order to 
determine their involvement in gastric ulcers as well as any other pathogenic features in the 
Vhembe district.  
Over the past few years, enteroaggregative E. coli have been increasingly characterized in 
developing countries and recent data have suggested that EAEC are emerging as diarrheal 
agents in developed nations as well (Nataro et al., 2006; Opintan et al., 2010). However; the 
true distribution of these organisms as well as their pathogenicity is not well studied in 
South Africa particularly in the Vhembe district. In the present study, we detected the 
presence of three EAEC pathogenic genes employing a recently developed multiplex PCR. 
We evaluated these genes in relation to HIV status, diarrheal symptoms, intestinal 
inflammation, determined by elevated lactoferrin, and occult blood in a sample population 
composed of hospital patients with known HIV status and school children in the Vhembe 
district of South Africa. Different methods have been described for the detection of EAEC 
and have suggested the existence of two different categories of EAEC including Typical and 
Atypical EAEC (Jenkins et al., 2006). Typical EAEC carry the pAA plasmid originally 
detected by the AA probe. Enteroaggregative E. coli have also been associated with 
weakened immune system such as in patients with HIV and AIDS. EAEC have been 
described as the most common pathogen among HIV positive patients in many countries 
even though the rates of infection vary from country to country. In this study we found a 
higher rate of EAEC infection among HIV positive patients (29.5%) compared to Senegal 
(West Africa) where EAEC was found in 19.6 % of HIV patients and was the most common 
pathogen amongst these individuals (Gassama et al., 2001). In Switzerland, EAEC genes 
were detected in 22% of HIV positive patients with diarrhea while in Zambia, EAEC was 
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found in both HIV patients and control even though cytotoxic phenotypes were only 
isolated from the AIDS patients with no evidence of seasonality in the frequency of 
isolation, and no evidence of long-term carriage (Kelly et al., 2003; Crump et al., 2011).   
Different markers of pathogenesis have been described in EAEC infections including fecal 
cytokines such as IL-8 and IL-1R, lactoferrin, and occult blood (Steiner et al., 1998, Greenberg 
et al., 2002). Volunteer challenge studies have demonstrated heterogeneity in the ability of 
EAEC isolates to cause disease and several studies have been unable to make clear 
associations with EAEC and diarrhea. In this study, more EAEC positive samples had 
elevated lactoferrin and diarrhea, and the presence of EAEC in the stools was significantly 
associated with occult blood (P<0.001). Although EAEC have been associated with bloody 
stool samples the relationship with occult blood has not been clearly described (Durrer et al., 
2000). A study in Central African Republic indicated that EAEC were the most frequently 
identified agents in HIV positive patients with persistent diarrhea and 42.8% of the patients 
with EAEC as sole pathogens had bloody diarrhea (Germani et al., 1998). The presence of 
occult blood in the stools of individuals infected with EAEC was tested in a previous study 
that did not find a significant association between EAEC infection and the presence of occult 
blood in the stools since only 4 (31.1%) of EAEC positive stool samples had occult blood, 
while 27 (60.0%) of EAEC positive stool samples had lactoferrin (Bouckenooghe et al., 2000). 
Our study is thus the first that found significant association between EAEC infections and 
occult blood in the stool and might indicate a different pathogenic manifestation of these 
organisms in this part of the world.  
Studies elsewhere have indicated that the best characterized E. coli pathotypes require 
multiple genes to be fully/highly virulent. For example enterotoxigenic E. coli (ETEC) with 
heat-labile toxin (LT), heat-stable toxin (ST) and colonization factor antigens (CFAs) are the 
most virulent; Enteropathogenic E. coli (EPEC) with Bundle Forming Pilus (BFP) and the eae 
gene encoding the adhesin intimin, responsible for the intimate attachment of the bacteria to 
the epithelial cell are most virulent; Shiga-toxin-producing E. coli (STEC) with Shiga-like 
toxin (Stx) and eaeA, encoding intimin involved in attachment of bacteria to enterocytes and 
plasmid are most virulent (Qadri et al., 2000 ; Rappelli et al., 2001 ; Scaletsky et al., 2002 ; 
Karch et al., 2006; Turner et al., 2006;  Medina et al., 2010). However, the presence of multiple 
genes has not been associated with pathogenesis in EAEC. This study has shown that strains 
with all the three genes were more pathogenic in terms of diarrhea production, intestinal 
inflammation indicated by the lactoferrin level in the stools and occult blood.   
Two species of microsporidia, Enterocytozoon bieneusi and Encephalitozoon (Septata) 
instestinalis, are known to cause intestinal microsporidiosis. Even though E. bieneusi is 
responsible for about 90% of reported infections (Orenstein, 1994), other microsporidial 
species such as the Vittaforma-like species were recently described in stool samples from 
both HIV positive and HIV negative individuals in Portugal (Sulaiman et al., 2003).  In our 
study, only E. bieneusi was detected in stool samples, even though the PCR method used 
could detect all of the Encephalitozoon spp. in addition to E. bieneusi. Other studies have also 
indicated that E. bieneusi was the most common microsporidia infecting HIV negative as 
well as HIV positive individuals (Sarfati et al., 2006) and that PCR based assays can be used 
successfully for microsporidian species differentiation from stool specimens, thus obviating 
the need for invasive biopsy procedures (Liguory et al., 1997).  
To date, the pathogenicity of Microsporidia is not clearly defined and the mechanisms by 
which Microsporidia induce diarrhea in HIV patients have not been determined. A wide 
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range of pathology has been associated with Microsporidia; these include inflammation and 
cell death, and symptoms such as shortness of breath, sinusitis, and diarrhea with wasting 
(Orenstein, 2003; Stark et al., 2009). In our study we found that even though HIV positive 
patients infected by E. bieneusi had more diarrhea than those non-infected, they actually had 
less inflammation as compared to the non-infected HIV positive individuals as 
demonstrated by the lactoferrin test. This could be explained by the occurrence of multiple 
infections in these individuals. The high level of lactoferrin could thus be due to infections 
by other organisms such as Cryptosporidium spp, Entamoeba histolytica, Enteroaggregative E. 
coli, Clostridium difficile and Campylobacter jejuni / coli also found in these stool samples.  
Compared to previous studies we have conducted in the same region, E. bieneusi was more 
common than Cryptosporidium spp among HIV patients (Samie et al., 2006a). However, HIV 
positive patients infected with Cryptosporidium had more diarrhea and more lactoferrin than 
those who were not infected, indicating that the expected outcome would be worse with 
Cryptosporidium than with E. bieneusi in this population. This observation is similar to those 
described by Bern et al. (2005) in Peru, where microsporidiosis did not appear to have a 
major impact on survival among AIDS patients compared to cryptosporidiosis, even though 
some genotypes of E. bieneusi caused chronic diarrhea in these patients.   
E. bieneusi was not associated with intestinal inflammation in our study, as demonstrated by 
the lactoferrin test in HIV negative and HIV positive individuals even though most HIV 
positive individuals without microsporidia had elevated lactoferrin, indicating high level of 
intestinal inflammation. This could be due to the effect of HIV itself as previously 
demonstrated (Kotler et al., 1993; Maingat et al., 2011). This is in line with some studies 
where multiple small intestinal biopsies showed atrophy with acute and chronic 
inflammation in HIV seropositive individuals even without apparent pathogens (Orenstein 
et al., 1992; Snijders et al., 1995; Idris et al 2010). It thus suggests that microsporidia might be 
cause of secretory diarrhea in HIV patients while most HIV negative individuals remain 
asymptomatic in the Vhembe district.   
This study also determined the prevalence of community acquired C. difficile toxigenic 
characteristics among hospital outpatients and school children and evaluated the association 
between different pathologic features and the presence and toxigenic profiles of the isolates. 
C. difficile was less frequent among apparently healthy school children. The two positive 
samples obtained from the schools were non toxigenic as opposed to the toxigenic strains 
obtained from the hospital outpatients. We also identified the existence of a mutation on the 
tcdC gene associated with increased virulence of associated C. difficile infections and this is in 
harmony with a previous repport (Cloud et al., 2007). The prevalence of C. difficile associated 
diarrhea among HIV patients have been demonstrated to vary according to different studies 
(Cappell 1993; Lu 1994).  In a study of C difficile associated diarrhea among HIV positive 
patients in Illinois, USA, CDAD was observed in 32% of all study patients with diarrhea 
especially those with advanced HIV disease (Pulvirenti et al., 2002). Other reports have 
suggested that clinical manifestations and response to therapy in HIV infected patients with 
C. difficile associated diarrhea (CDAD) were similar to that of patients without HIV (DeLalla 
1992; Hutin 1993; Cozart 1993) while others have noted a more severe, refractory 
presentation in HIV infected patients (Colarian 1988; Beaugerie 1994). In our study C. difficile 
did not appear to be associated with HIV. However like other studies, our HIV population 
was very little (44 patients) and was not clearly characterized in terms of CD4+ counts or 
HIV disease state. Thus more studies are needed to confirm the role of C. difficile as diarrheal 
agent among HIV positive patients in the Vhembe district and in South Africa in general. 
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Toxin-A-negative, toxin-B-positive (A- B+) Clostridium difficile isolates were identified in 
several studies (Wultanska et al., 2005). We found that only 3 (6.7%) of all C. difficile positive 
samples were A-B+ variants which is lower compared to those found in horses by Arroyo et 
al., (2007) and around the same level as those described by Pituch et al, (2003) in Poland were 
about 7% of the strains isolated from CDAD patients had the variant A-B+ isolates. Recent 
studies have also reported on the existence of cluster of A- B+ C. difficile, universally 
resistant to the fluoroquinolones tested including ofloxacin, ciprofloxacin, levofloxacin, 
moxifloxacin and gatifloxacin, with MICs > 32 mg/mL, associated with a novel transversion 
mutation in gyrB (Drudy et al., 2006). The high prevalence of A-B+ C. difficile strains might 
have a negative impact on the detection of toxigenic C. difficile in stool samples when the 
ELISA test is used. This further underscores the importance of the implementation of 
molecular methods in the detection and characterization of C. difficile in specific settings. 
5. Conclusions 
The quantitative real time PCR using SYBR green is a simple and fast method for the 
detection of different infectious organisms including bacteria and parasites.  Different pre-
treatment methods can be used to improve DNA purification for the detection of bacterial 
and parasitic organisms in stool samples for molecular epidemiological studies. These 
include the alkaline treatment of the stool sample, the use of the freeze and thaw and the use 
of glass beads prior to DNA purification by the traditional phenol chloroform method or the 
use of different kits such as the Qiagen. This study has demonstrated a high prevalence of 
microsporidia, Cryptosporidium infections in the Vhembe district and its implications in the 
production of diarrhea and inflammation. C. hominis was more common and related to 
pathogenesis than C. parvum. HIV positive patients did not appear to be more likely to be 
infected by Cryptosporidium. However, more studies are needed using larger number of HIV 
positive samples.  The study of antigenic profiles of these organisms will provide insight for 
the development of effective vaccines. 
E histolytica appears to be common in the Vhembe district of South Africa. Mixed infections 
were especially frequent as opposed to other areas in the world such as Japan (Ali et al., 
2003). E. dispar was less associated with diarrhea or fecal lactoferrin and occurred more often 
than E. histolytica in the general population. Fecal lactoferrin may provide a useful indicator 
of acute invasive E. histolytica infections and could be used as screening test for 
inflammatory diarrhea including E. histolytica in the Vhembe district considering its 
simplicity. This study also shows the susceptibility of females infected with HIV to E. 
histolytica, which is also commonly seen in males with or without HIV. The study of genetic 
and antigenic profiles will shed more light on the pathogenicity of this important protozoal 
infection and provide insight into improved control measures such as improved water and 
sanitation, vaccine and drug development. 
We successfully used different PCR methods for the detection and identification of 
Enteroaggregative E. Coli, Campylobacter, Helicobacter and Arcobacter spp from stool samples. 
Of interest was the development of a fast and efficient real time PCR using SYBR GREEN for 
the detection of C. concisus. EAEC was an important etiological agent of diarrhea in the 
Vhembe district, South Africa as indicated by its high prevalence among hospital patients 
and particularly among HIV positive patients.  Furthermore, EAEC may be a treatable cause 
of diarrhea in patients with AIDS (Wanke et al., 1998b). Toxigenic C. difficile was associated 
with pathologic conditions among the patients. Typical preventive measures against 
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infections by these organisms include careful personal hygiene, especially promotion of 
hand washing through health education programs. Major therapeutic intervention for all 
individuals with diarrhea consists of fluid and electrolyte therapy. However, when 
antimicrobial therapy is appropriate, selection of a specific agent should be made based 
upon susceptibility patterns of the pathogen or information on local susceptibility 
patterns.  
Quantitative real time PCR showed that a certain threshold, related to the number of cells, 
was needed for the EAEC to cause pathologic symptoms such as diarrhea and inflammation. 
HIV positive individuals are at a higher risk of infection by EAEC and had higher level of 
lactoferrin when compared to HIV negative individuals. This is the first study to 
significantly associate EAEC with the presence of occult blood in the stools which might be 
due to pathogenic factors such as the plasmid encoded toxin (Pet) which is highly 
homologous to the EspP protease of EHEC and to EspC of EPEC as well as the protein 
involved in colonization (Pic) . 
The current study has demonstrated that E. bieneusi is the most common microsporidian 
species occurring in the Vhembe district particularly among HIV positive patients and E. 
bieneusi is a cause of secretory diarrhea among HIV positive individuals as opposed to 
inflammatory diarrhea. This study has demonstrated that the pathogenicity of 
Enteroaggregative E. coli could be directly related to the genetic profile of the infecting 
strains. This is important in the understanding of the pathogenicity of these organisms with 
possible effect on the development of control methods including diagnostics, drug target 
molecules (genes) and vaccination procedures. This study also associated EAEC infections 
with occult blood which might indicate a possible relation/link between the pathogenicity 
of this organism and that of Enterohemorrhagic E. coli (EHEC) often involved in hemolytic 
uremic syndrome (HUS) and bloody diarrhea.  
The pathogenicity index determines the importance of the infecting agent as a pathogen in a 
specific community. The pathogenicity index indicated that E. histolytica, Cryptosporidium 
hominis, C. jejuni/coli,  C. concisus, Clostridium difficile and Enteroaggregative E. coli were the 
most diarrheagenic organisms in the Vhembe population while E. histolytica, C. jejuni/coli, C. 
concisus, Clostridium difficile were the most inflammatory. Enteroaggregative E. coli was the 
most associated with occult blood followed by E. histolytica, C. jejuni/coli, and Clostridium 
difficile. This further indicates the importance of the lactoferrin and occult tests as screening 
methods for diarrheal organisms in hospitals and will probably reduce the cost of infectious 
diarrheal diagnosis and improve the quality of service. HIV positive patients are more 
susceptible to infections, therefore, the implementation of molecular methodologies is 
recommended for an improved diagnosis of gastrointestinal infections among these patients 
and the quality of their lives. Diarrheal diseases can be prevented through access to clean, 
safe drinking water and through proper sanitation measures, including hand washing and 
safe disposal of human waste. Thus increased health education in schools as well as in the 
communities is highly recommended and could help prevent the transmission of diarrheal 
diseases in the population. Proper management and treatment of waste and waste water is 
recommended through increased investments in water and sanitation systems at least in fast 
growing areas.  Such strategies could alleviate a great deal of unnecessary suffering and loss 
of productivity; reduce the number of lives lost to these diseases, and result in significant 
savings in health care costs.  
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